• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Review: Borneol’s Complex CNS Mechanisms and Evidence Gaps

by
November 10, 2026
in Health
Reading Time: 2 mins read
0
Review: Borneol's Complex CNS Mechanisms and Evidence Gaps

Review: Borneol's Complex CNS Mechanisms and Evidence Gaps

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive review published in Frontiers in Pharmacology examines the pharmacological effects and mechanisms of borneol and borneol-containing formulations in central nervous system diseases. The study, authored by researchers from the Encephalopathy Center at the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, integrates existing evidence to compare how borneol influences various pathophysiological processes across different neurological conditions. The review highlights that while borneol is widely used in traditional Chinese medicine, its specific therapeutic value and long-term safety remain areas requiring rigorous investigation.

Borneol is an aromatic medicinal agent that serves both as a standalone component and as an ingredient in multi-herb formulations. Its relevance to central nervous system disorders has attracted increasing attention, particularly in the context of Alzheimer’s disease, Parkinson’s disease, epilepsy, ischemic stroke, and glioma. The review notes that accumulating evidence suggests borneol may influence multiple pathophysiological processes, including brain-barrier function and drug delivery, neuroinflammation and oxidative stress, neurotransmitter homeostasis and neuronal excitability, cellular injury and death, and the clearance of pathological substances and post-injury repair.

The authors integrate and compare these mechanisms across different disease contexts to identify patterns and discrepancies. A notable finding is that while several actions of borneol appear to converge across central nervous system disorders, others are strongly disease- and context-dependent. For instance, the effects of borneol on brain-barrier permeability, oxidative stress, and cell death may differ in direction depending on the specific disease pathology and the intended therapeutic outcome.

Pharmacokinetic studies support measurable brain exposure to borneol. However, the review points out that direct comparative evidence regarding pharmacological activity, brain disposition, and human pharmacokinetics among borneol preparations of different botanical origins and stereochemical configurations remains scarce.

Borneol-containing formulations exhibit multi-level pharmacological effects, but the review emphasizes a significant limitation in the current evidence base. Most studies lack borneol-alone, borneol-depleted, or add-back controls, which means that the observed effects cannot be unequivocally attributed to borneol itself.

The current evidence base is dominated by cellular and animal studies, with several proposed mechanisms inferred primarily from changes in molecular expression or computational predictions. The review notes that robust causal validation, high-quality clinical evidence, and long-term safety data are still limited.

Future studies should focus on defining the dose–exposure–response relationships and disease-specific therapeutic windows of different borneol preparations. Additionally, research is needed to establish the independent contribution of borneol within complex formulations, which will clarify its specific role in multi-herb treatments. The review calls for rigorous mechanistic and clinical investigation to determine the genuine therapeutic value and long-term safety of borneol.

Subject of Research: Pharmacological effects and mechanisms of borneol in central nervous system diseases

Article Title: Recent advances in the pharmacological effects and mechanisms of borneol and borneol-containing formulations in central nervous system diseases

Article References: Zhang, X., Wu, Y., Han, J., Zhao, Z., Yao, Y., Sun, Y., & Wang, X. (2026). Recent advances in the pharmacological effects and mechanisms of borneol and borneol-containing formulations in central nervous system diseases. Frontiers in Pharmacology, 17, Article 1950139. https://doi.org/10.3389/fphar.2026.1950139

Image Credits: AI Generated

DOI: 10.3389/fphar.2026.1950139

Keywords: borneol, central nervous system, pharmacology, traditional Chinese medicine, neuroinflammation, Alzheimer's disease, Parkinson's disease, drug delivery, pharmacokinetics, review, Recent, advances

News Source: Cassandra Pierce. (November 10, 2026). Review: Borneol’s Complex CNS Mechanisms and Evidence Gaps. Scienmag.

Tags: advancesAlzheimer's diseaseborneolcentral nervous systemDrug deliveryNeuroinflammationParkinson’s diseasePharmacokineticspharmacologyRecentReviewtraditional Chinese medicine
Share12Tweet7Share2ShareShareShare1

Related Posts

Clinical Task Involvement Linked to Higher Job Satisfaction Among Community Pharmacists

Clinical Task Involvement Linked to Higher Job Satisfaction Among Community Pharmacists

November 17, 2026
Voronoi Density Influences Human Fibroblast Adhesion on Porous Titanium Implants

Voronoi Density Influences Human Fibroblast Adhesion on Porous Titanium Implants

November 17, 2026

Community Trust Presents Opportunities to Strengthen Non-Communicable Disease Prevention in Ethiopia

November 17, 2026

A Third of Barcelona Detainees With Active Hepatitis C Are Undiagnosed

November 17, 2026

POPULAR NEWS

  • De Novo Unbalanced X;14 Translocation Linked to Turner Syndrome Phenotype

    De Novo Unbalanced X;14 Translocation Linked to Turner Syndrome Phenotype

    29 shares
    Share 12 Tweet 7
  • Nepal Survey Finds Stable Drug-Resistant Tuberculosis Rates Alongside Rising Fluoroquinolone Resistance

    29 shares
    Share 12 Tweet 7
  • Systematic Review Finds No Clear Mortality Benefit Across Six Sepsis Treatments

    29 shares
    Share 12 Tweet 7
  • Surgical Internet of Medical Things Faces Cyber Threats Endangering Patient Safety

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Clinical Task Involvement Linked to Higher Job Satisfaction Among Community Pharmacists

Gellan Gum and Hydrocolloids Control Anthocyanin Dissolution in Vegan Jelly Candies

Voronoi Density Influences Human Fibroblast Adhesion on Porous Titanium Implants

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.